MOTS Stock Overview
Motus GI Holdings, Inc. operates as a medical technology company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Motus GI Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.07 |
| 52 Week High | US$23.40 |
| 52 Week Low | US$0.067 |
| Beta | 1.29 |
| 1 Month Change | -86.79% |
| 3 Month Change | -93.58% |
| 1 Year Change | -99.45% |
| 3 Year Change | -99.98% |
| 5 Year Change | -99.99% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Motus GI regains compliance with minimum bid price requirement
Aug 11Motus GI Holdings announces 1-for-20 reverse stock split to satisfy Nasdaq's minimum bid requirement
Jul 25Motus GI starts enrollment in Pure-Vu System EU study
Jun 16Motus GI shares rocket 55% on FDA 510(k) clearance of Pure-Vu System
Apr 30Here's Why Motus GI Holdings (NASDAQ:MOTS) Can Manage Its Debt Despite Losing Money
Mar 02
Shareholder Returns
| MOTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -83.4% | -4.4% | -3.7% |
| 1Y | -99.5% | -2.8% | 20.2% |
Return vs Industry: MOTS underperformed the US Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: MOTS underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| MOTS volatility | |
|---|---|
| MOTS Average Weekly Movement | 31.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MOTS's share price has been volatile over the past 3 months.
Volatility Over Time: MOTS's weekly volatility has increased from 23% to 31% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 15 | Mark Pomeranz | www.motusgi.com |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
Motus GI Holdings, Inc. Fundamentals Summary
| MOTS fundamental statistics | |
|---|---|
| Market cap | US$364.76k |
| Earnings (TTM) | -US$12.87m |
| Revenue (TTM) | US$319.00k |
1.1x
P/S Ratio0.0x
P/E RatioIs MOTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOTS income statement (TTM) | |
|---|---|
| Revenue | US$319.00k |
| Cost of Revenue | US$569.00k |
| Gross Profit | -US$250.00k |
| Other Expenses | US$12.62m |
| Earnings | -US$12.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.47 |
| Gross Margin | -78.37% |
| Net Profit Margin | -4,033.54% |
| Debt/Equity Ratio | 84.6% |
How did MOTS perform over the long term?
See historical performance and comparison